Evidence map›Paper›PMID 39169229›Full record

ArticleEuropean journal of human genetics : EJHG2024

Autosomal dominant stromal corneal dystrophy associated with a SPARCL1 missense variant.

Freddie L Braddock, Jessica C Gardner, Nihar Bhattacharyya, Beatriz Sanchez-Pintado, Marcos Costa, Christina Zarouchlioti, Anita Szabo, Petra Lišková, Michael E Cheetham, Robert D Young and 4 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. New guidelines for rare cancer syndromes.European journal of human genetics : EJHG · 2024
    Article
  3. SPARCL1 sparkles new insight into corneal dystrophies.European journal of human genetics : EJHG · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Freddie L BraddockUCL Institute of Ophthalmology, University College London, London, UK.ORCID 0009-0008-0754-1834
Jessica C GardnerUCL Institute of Ophthalmology, University College London, London, UK.ORCID 0000-0002-7053-0707
Nihar BhattacharyyaUCL Institute of Ophthalmology, University College London, London, UK.
Beatriz Sanchez-PintadoUCL Institute of Ophthalmology, University College London, London, UK.
Marcos CostaUCL Institute of Ophthalmology, University College London, London, UK.
Christina ZarouchliotiUCL Institute of Ophthalmology, University College London, London, UK.ORCID 0000-0002-5096-177X
Anita SzaboUCL Institute of Ophthalmology, University College London, London, UK.
Petra LiškováDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Michael E CheethamUCL Institute of Ophthalmology, University College London, London, UK.
Robert D YoungStructural Biophysics Group, School of Optometry & Vision Sciences, Cardiff University, Cardiff, UK.
Caroline ThaungUCL Institute of Ophthalmology, University College London, London, UK.ORCID 0000-0002-8318-046X
Alice E DavidsonUCL Institute of Ophthalmology, University College London, London, UK.ORCID 0000-0002-1816-6151
Stephen J TuftUCL Institute of Ophthalmology, University College London, London, UK.ORCID 0000-0001-8192-5192
Alison J HardcastleUCL Institute of Ophthalmology, University College London, London, UK. a.hardcastle@ucl.ac.uk.ORCID 0000-0002-0038-6770

Funding

Wellcome Trust
6 · The paper itself

Abstract

Corneal dystrophies are phenotypically and genetically heterogeneous, often resulting in visual impairment caused by corneal opacification. We investigated the genetic cause of an autosomal dominant corneal stromal dystrophy in a pedigree with eight affected individuals in three generations. Affected individuals had diffuse central stromal opacity, with reduced visual acuity in older family members. Histopathology of affected cornea tissue removed during surgery revealed mild stromal textural alterations with alcianophilic deposits. Whole genome sequence data were generated for four affected individuals. No rare variants (MAF < 0.001) were identified in established corneal dystrophy genes. However, a novel heterozygous missense variant in exon 4 of SPARCL1, NM_004684: c.334G > A; p.(Glu112Lys), which is predicted to be damaging, segregated with disease. SPARC-like protein 1 (SPARCL1) is a secreted matricellular protein involved in cell migration, cell adhesion, tissue repair, and remodelling. Interestingly, SPARCL1 has been shown to regulate decorin. Heterozygous variants in DCN, encoding decorin, cause autosomal dominant congenital stromal corneal dystrophy, suggesting a common pathogenic pathway. Therefore, we performed immunohistochemistry to compare SPARCL1 and decorin localisation in corneal tissue from an affected family member and an unaffected control. Strikingly, the level of decorin was significantly decreased in the corneal stroma of the affected tissue, and SPARCL1 appeared to be retained in the epithelium. In summary, we describe a novel autosomal dominant corneal stromal dystrophy associated with a missense variant in SPARCL1, extending the phenotypic and genetic heterogeneity of inherited corneal disease.

Indexed as

Calcium-Binding ProteinsCorneal Dystrophies, HereditaryExtracellular Matrix ProteinsMutation, MissensePedigreeAdultAgedCorneal StromaDecorinFemaleHeterozygoteHumansMaleMiddle AgedCalcium-Binding ProteinsDecorinExtracellular Matrix ProteinsSPARCL1 protein, human

Identifiers

PMID39169229
PMCPMC11607396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.